FDA Adverse Event Malfunction Summary report: N

LS LF PP PRIM SYM SET PGB W/BCKCK V 2 CL

MDR report key: 2181292 · Received July 8, 2011

Report

Report Number
9615050-2011-00499
Event Type
Malfunction
Date Received
July 8, 2011
Date of Event
April 25, 2011
Report Date
June 14, 2011
Manufacturer
HOSPIRA COSTA RICA LTD.
Product Code
FPA
PMA / PMN Number
K103344
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE IS EXPECTED TO BE RETURNED FOR INVESTIGATION. IT HAS NOT YET BEEN RECEIVED. THIS REPORT REPRESENTS ALL THE INFO KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL.

Description of Event or Problem · 1

THE CUSTOMER CONTACT REPORTED BACKFLOW OF FLUID FROM THE SECONDARY SOLUTION CONTAINER INTO THE PRIMARY TUBING SET. THE PRIMARY TUBING SET WAS BEING USED TO DELIVER AN UNSPECIFIED MEDICATION AT AN UNSPECIFIED RATE VIA A SYMBIQ PUMP. AT AN UNSPECIFIED TIME, THE MALE ADAPTER OF A SECONDARY TUBING SET WAS CONNECTED AT AN UNSPECIFIED LOCATION ON THE PRIMARY TUBING SET FOR PIGGYBACK DELIVERY OF AN UNSPECIFIED CONCENTRATION OF TAZOCIN AND FLAGYL. AFTER AN UNSPECIFIED LENGTH OF TIME IN USE, BACKFLOW OF SOLUTION FROM THE SECONDARY TUBING SET INTO THE PRIMARY TUBING SET WAS NOTED. IT WAS REPORTED THAT THE SECONDARY TUBING SET WAS CLAMPED AND THE PRIMARY TUBING SET REMAINED IN CLINICAL USE. THERE WERE NO REPORTED ADVERSE PT EFFECTS AND NO REPORTED DELAY OF THERAPY CRITICAL TO THIS PT. NO MEDICAL INTERVENTIONS WERE REQUIRED. THOUGH REQUESTED, NO ADD'L INFO WAS PROVIDED INCLUDING IF SECONDARY TUBING SET WAS REPLACED AND THE THERAPY WAS RESUMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LS LF PP PRIM SYM SET PGB W/BCKCK V 2 CL 80FPA FPA HOSPIRA COSTA RICA LTD. NA 911685H

Patients

Seq Age Sex Outcome Treatment
1 UNK SYMBIQ PUMP, LIST #UNK, SN UNK| UNSPECIFIED SECONDARY TUBING SET, LIST #UNK| LOT #UNK